Coway\'s 2024 Q4 revenue reached KRW 1,125.7 billion (+12.1% YoY) with an operating profit amounted to KRW 183.4 billion (+10.4% YoY)
Leveraging multimodal AI to create high-quality product detail pages for e-commerce—completing texts,images,and layouts in 15–30 seconds
HANGZHOU,China,Feb. 14,2025--WORK Medical Technology Group LTD ("WORK Medical" or the "Company") (Nasdaq: WOK),a supplier of medical devices in China,today reported its financial r
SHANGHAI and NANJING,China and SAN JOSE,Calif.,Feb. 14,2025-- IASO Biotherapeutics ("IASO Bio"),a biopharmaceutical company focused on the discovery,development,manufacturing,and commerciali
XI\'AN,China,Feb. 14,2025-- LONGi has announced the retention of its AAA rating in PV-Tech\'s Q4 2024 PV ModuleTech bankability ratings,marking the company\'s 20th consecutive quarter at this top tie
XUN COUNTY,China,Feb. 14,2025-- On February 6,2025,the ninth day of the first lunar month,the 17th Central Plains (Hebi) Folk Culture Festival ushered in the Dapishan Temple Fair. The event was a vibr
HONG KONG,Feb. 14,2025-- On February 14,2025,China Telecom officially announced that the capacity of the Asia Direct Cable (ADC),an international submarine cable initiative led by China Telecom,has be
SHENZHEN,China,Feb. 14,2025-- Omdia released the Omdia Universe: CloudOps,2025 report recently. In the report,Huawei was ranked No. 1 globally in CloudOps in terms of strategy and execution,and No. 2
Landmark Collaboration Redefines Enterprise Data Management and Unleashes the Full Potential of Agentic AI
XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).
